New targets and new drugs down under in 2004

Sheila A Doggrell1

  • 1University of Queensland, School of Biomedical Sciences, Australia. s_doggrell@yahoo.com

Insights

This congress highlighted advances in medical research, focusing on stress-activated protein kinases, early cancer treatment, and genetic modeling of heart disease. Discussions also covered personalized exercise responses and translating research into clinical practice.

Area of Science:

  • Health and Medical Research
  • Biomedical Sciences
  • Clinical Practice

Background:

  • The Second Australian Health and Medical Research Congress convened diverse specialist societies.
  • Keynote lectures addressed critical areas in molecular biology and disease treatment.
  • Symposia focused on translational research and emerging therapeutic strategies.

Purpose of the Study:

  • To present and discuss cutting-edge research across various health and medical disciplines.
  • To foster collaboration and knowledge exchange among researchers and clinicians.
  • To explore novel therapeutic targets and treatment modalities.

Main Methods:

  • Plenary lectures on signal transduction, early cancer detection, genetic modeling of cardiomyopathies, and biological individuality.
  • Symposia covering translation of basic research, anticancer therapies, signaling pathway modulation, bone and joint diseases, statin effects, and angiogenesis inhibitors.

Main Results:

  • Exploration of stress-activated mitogen-activated protein kinases in cellular signaling.
  • Discussion on the potential for pre-symptomatic cancer treatment.
  • Advancements in modeling human cardiomyopathies using genetic manipulation in animal models.
  • Investigation into biological individuality and exercise response.

Conclusions:

  • The congress showcased significant progress in understanding and treating complex diseases.
  • Emphasis was placed on the importance of interdisciplinary collaboration for medical advancement.
  • Future research directions included targeted therapies and personalized medicine approaches.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.